Biopharmx (NYSEAMERICAN:BPMX) posted its quarterly earnings results on Thursday. The biotechnology company reported ($0.01) earnings per share for the quarter, beating the Zacks’ consensus estimate of ($0.02) by $0.01, Fidelity Earnings reports. The company had revenue of $0.01 million during the quarter.
Shares of NYSEAMERICAN BPMX opened at $0.10 on Friday. Biopharmx has a 12 month low of $0.05 and a 12 month high of $0.33.
WARNING: “Biopharmx (BPMX) Announces Earnings Results” was originally reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this article on another website, it was illegally stolen and reposted in violation of United States & international copyright & trademark law. The correct version of this article can be read at https://www.dispatchtribunal.com/2019/03/15/biopharmx-bpmx-announces-earnings-results.html.
BioPharmX Corporation, a specialty pharmaceutical company, develops and commercializes novel prescription and over-the-counter (OTC) products that address dermatology and women's health markets. The company offers VI2OLET, an OTC molecular iodine dietary supplement that addresses cyclic breast discomfort, as well as alleviates the symptoms of fibrocystic breast condition (FBC).
Featured Article: What is insider trading?
Receive News & Ratings for Biopharmx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biopharmx and related companies with MarketBeat.com's FREE daily email newsletter.